• Title of article

    Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway

  • Author/Authors

    Ilan Gabriely، نويسنده , , Xiao Man Yang، نويسنده , , Jane A. Cases، نويسنده , , Xiao Hui Ma، نويسنده , , Luciano Rossetti، نويسنده , , Nir Barzilai، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2002
  • Pages
    8
  • From page
    115
  • To page
    122
  • Abstract
    We examined whether acute in vivo increases in either plasma glucose or insulin concentrations stimulate PAI-1 gene expression in fat tissue. We studied chronically catheterized unstressed and awake, lean ( 300 g, n=12) and obese ( 450 g, n=12) Sprague–Dawley rats. Hyperglycemia ( 18mM) was induced for 3 h by glucose infusion during a pancreatic clamp (somatostatin inhibited endogenous insulin secretion). Compared with equivalent saline infusion, hyperglycemia induced a 6–7 fold increase in PAI-1 gene expression in both lean and obese rats (P<0.001). When the rate of cellular glucose uptake was matched during a euglycemic hyperinsulinemic ( 60 μU/ml) clamp, PAI-1 gene expression in both obese and lean rats was proportionately and significantly increased (P<0.001). We further examined whether induction of the hexosamine biosynthetic pathway would mimic the effects of hyperglycemia and hyperinsulinemia on PAI-1 gene expression. Indeed, infusion of glucosamine (GlcN, 30 μmol/kg/min), induced a 3–4 fold increase (P<0.01) in PAI-1 gene expression in both lean and obese animals. While obese rats had a four times greater fat mass then the lean rats, PAI-1 gene expression remained significantly higher when expressed as per gram fat. Our results support the hypothesis that increased glucose uptake induces PAI-1 gene expression in adipose tissue, probably through the activation of the hexosamine biosynthetic pathway. These findings may account for some of the fibrinolytic alterations seen in obese type 2 diabetic humans.
  • Keywords
    glucose , obesity , diabetes mellitus , insulin resistance , Hexosamine biosynthetic pathway , Plasminogen activator inhibitor type-1
  • Journal title
    Atherosclerosis
  • Serial Year
    2002
  • Journal title
    Atherosclerosis
  • Record number

    630605